Human papillomavirus (HPV) is responsible for a significant number of cancers globally, including the majority of cervical cancers. Biotechnological advancements have allowed the development of vaccines that not only curb the prevalence of this virus but also promise a future with a reduced burden of HPV-associated diseases [1]. Recombinant DNA Technology The foundational technology behind […]
